review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Sheldon W. Tobe | Q58091532 |
Marcel Lebel | Q75131540 | ||
P2093 | author name string | Finlay A McAlister | |
Janusz Kaczorowski | |||
Norman R C Campbell | |||
Canadian Hypertension Education Program | |||
Richard Z Lewanczuk | |||
Luc Poirier | |||
Ross Feldman | |||
Margaret Moy Kwong | |||
P2860 | cites work | The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors | Q21563399 |
Results of the Ontario survey on the prevalence and control of hypertension | Q24643898 | ||
The BpTRU automatic blood pressure monitor compared to 24 hour ambulatory blood pressure monitoring in the assessment of blood pressure in patients with hypertension | Q24815566 | ||
Choices, persistence and adherence to antihypertensive agents: evidence from RAMQ data | Q31152110 | ||
Telmisartan, ramipril, or both in patients at high risk for vascular events | Q33156143 | ||
Persistence with treatment for hypertension in actual practice | Q34030347 | ||
Telmisartan to prevent recurrent stroke and cardiovascular events | Q34596294 | ||
The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy | Q34607311 | ||
Automated measurement of blood pressure in routine clinical practice | Q36775246 | ||
Prehypertension and hypertension in a primary care practice. | Q36936509 | ||
Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use | Q37026089 | ||
Trends in antihypertensive drug prescriptions and physician visits in Canada between 1996 and 2006 | Q37098424 | ||
Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis | Q37660789 | ||
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial | Q42542786 | ||
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients | Q46217490 | ||
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. | Q46426098 | ||
Automated oscillometric blood pressure versus auscultatory blood pressure as a predictor of carotid intima-medial thickness in male firefighters | Q47842384 | ||
Automated assessment of blood pressure using BpTRU compared with assessments by a trained technician and a clinic nurse | Q47858344 | ||
Comparison between an automated and manual sphygmomanometer in a population survey | Q47960913 | ||
Large increases in hypertension diagnosis and treatment in Canada after a healthcare professional education program. | Q50789154 | ||
Automated blood pressure measurement in routine clinical practice. | Q51248315 | ||
Increases in Antihypertensive Prescriptions and Reductions in Cardiovascular Events in Canada | Q59139520 | ||
Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175 634 patients | Q60630346 | ||
Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study | Q81791299 | ||
Awareness and misconception of hypertension in Canada: results of a national survey | Q81820761 | ||
Another major role for dietary sodium reduction: improving blood pressure control in patients with resistant hypertension | Q84264453 | ||
P433 | issue | 5 | |
P921 | main subject | arterial hypertension | Q41861 |
P304 | page(s) | 236-240 | |
P577 | publication date | 2010-05-01 | |
P1433 | published in | The Canadian Journal of Cardiology | Q3502278 |
P1476 | title | 2010 Canadian Hypertension Education Program (CHEP) recommendations: the scientific summary - an update of the 2010 theme and the science behind new CHEP recommendations | |
P478 | volume | 26 |
Q48185429 | Antihypertensive Treatment is associated with MRI-Derived Markers of Neurodegeneration and Impaired Cognition: A Propensity-Weighted Cohort Study |
Q35671059 | Canadian initiatives to prevent hypertension by reducing dietary sodium |
Q34001931 | Diabetes screening with hemoglobin A1c prior to a change in guideline recommendations: prevalence and patient characteristics. |
Q37786566 | Have the renin-angiotensin-aldosterone system perturbations in cardiovascular disease been exhausted? |
Q43197890 | Hypertension revisited. |
Q36618434 | Isolated Diastolic Hypertension among Adults in Saudi Arabia: Prevalence, Risk Factors, Predictors and Treatment. Results of a National Survey |
Q83918301 | Magnitude of the white-coat effect in the community pharmacy setting: the MEPAFAR study |
Q37881035 | Reviewing the benefits of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in diabetic nephropathy--are they drug specific or class specific? |
Q38389745 | Systematic Review of Clinical Practice Guidelines for the Improvement of Medication Adherence. |
Q34122611 | The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis |
Q37185973 | The management challenges of non-preeclampsia-related nephrotic syndrome in pregnancy |
Q38404425 | The use of drugs acting on the renin-angiotensin system and the incidence of pancreatic cancer |
Q61810087 | Trends in end digit preference for blood pressure and associations with cardiovascular outcomes in Canadian and UK primary care: a retrospective observational study |